Macrocycle Molecules for the Management of Systemic Infections: the Clarithromycin Paradigm

E-ISSN： 1873-4294|10|14|1470-1475

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.14, 2010-10, pp. : 1470-1475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clarithromycin extended-release in community-acquired respiratory tract infections

By Williams Kathy N Bishai William R

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2867-2876

Informa Healthcare

Access to resources Recommend Favorite

Analysis of Clarithromycin and Propicillin in the Management of Streptococcal Pharyngotonsillitis in Children

By Padilla N.

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 183-188

Adis International

Access to resources Recommend Favorite

Caspofungin - a novel antifungal agent for systemic infections

Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

New agents for treatment of systemic fungal infections

By Arikan S. Rex J.H.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 2, 2000-07 ,pp. : 135-160

Informa Healthcare

Access to resources Recommend Favorite

Management of systemic sclerosis

By Ong Voon H Brough Geraldine Denton Christopher P

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 214-219

Royal College Of Physicians

Access to resources Recommend Favorite